Phathom Pharmaceuticals, Inc. Common Stock (PHAT) Stock
NASDAQ · PHAT
7.45
Fundamentals
Market cap
$605.14M
Price / Earnings ratio
-6.1x
Price / Sales ratio
2.5x
Price / Book ratio
-1.8x
Return on assets
-0.6%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Phathom Pharmaceuticals, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees371
CEOMr. Steven L. Basta M.B.A.
IPO DateOct 25, 2019
HeadquartersFlorham Park, NJ
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Steven L. Basta M.B.A. | CEO, President & Director | 1966 |
| Mr. David A. Socks | Co-Founder | 1975 |
| Dr. Azmi Nabulsi M.D., M.P.H. | Co-Founder | 1960 |
| Mr. Sanjeev Narula | Chief Financial & Business Officer | 1961 |
| Ms. Anne Marie Cook Esq., J.D. | Chief Legal Officer & Corporate Secretary | 1962 |
| Mr. Jonathan Bentley | Senior VP and Head of Sales, Operations & Training | — |
| Mr. Robert Breedlove | VP of Finance & Principal Accounting Officer | — |
| Mr. Eric Sciorilli | Director of Business Development & Investor Relations | — |
| Mr. Bill Aprea J.D. | Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer | — |
| Ms. Nancy R. Phelan | Senior Vice President of Marketing & Analytics | 1969 |
Fundamentals
Valuation
Market cap$605.14M
Price-to-sales ratio2.52
Price-to-book value-1.76
Price-earnings ratio-6.10
Return on Equity39.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.26
Income Statement
Average volume1,166,742
EBITDA$-90.89M
1 year high (52w)$18.31
1 year low (52w)$7.47
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



